Thomas M. Engber

9.7k citations

61 papers · 5.3k indexed · 1 hit paper · h-index 34

Impact in

Cellular and Molecular Neuroscience top 0.2%
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
- Nerve injury and regeneration
- Neuropeptides and Animal Physiology
- Genetic Neurodegenerative Diseases
Neurology top 0.5%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments

Papers in

Physiology 10
- Adenosine and Purinergic Signaling 8
Cellular and Molecular Neuroscience 38
- Neurotransmitter Receptor Influence on Behavior 20
- Neuroscience and Neuropharmacology Research 14
- Neuropeptides and Animal Physiology 9

Co-authors: Thomas N. Chase Zvi Susel Charles R. Gerfen Lawrence C. Mahan Frederick J. Monsma David R. Sibley Stella M. Papa Robert C. Boldry
Journals: Brain Research (10 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)European Journal of Pharmacology (4 papers)Neuroscience (4 papers)Journal of Medicinal Chemistry (3 papers)
Partner nations: United States United Kingdom Spain

In The Last Decade

Thomas M. Engber

61 papers receiving 5.2k citations

Hit Papers

align trajectories log scale

D ₁ and D ₂ Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons 1990 · 2.4k citations

Peers

Countries citing papers authored by Thomas M. Engber

Since Specialization

Citations

This map shows the geographic impact of Thomas M. Engber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Engber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Engber more than expected).

Fields of papers citing papers by Thomas M. Engber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M. Engber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Engber. The network helps show where Thomas M. Engber may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas M. Engber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas M. Engber Line = papers co-authored together Thomas M. Engber links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons Experimental Neurology ·Yo Sasaki, Thomas M. Engber, Robert Hughes, Matthew D. Figley, Aldo Aguayo-Meléndez, Todd Bosanac, Rajesh Devraj, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio	2020	73
2	Synthesis of [1,2,4]triazolo[1,5-a]pyrazines as adenosine A2A receptor antagonists Bioorganic & Medicinal Chemistry Letters ·James J. Dowling, Humaedah Huma, Yoshiko Gogi, Per Samuelson, Cin Liu, G. Kumaravel, Thomas M. Engber, Xiaowei Jin, В. А. Пешехонова, Joy Wang, Kenjirou Kamijou, Russell C. Petter	2005	19
3	Effect of combined treatment with methylprednisolone and soluble Nogo‐66 receptor after rat spinal cord injury European Journal of Neuroscience ·Benxiu Ji, Mingwei Li, Stéphane Budel, R. Blake Pepinsky, Lee Walus, Thomas M. Engber, Stephen M. Strittmatter, Jane K. Relton	2005	46
4	Synthesis of alkyne derivatives of a novel triazolopyrazine as A2A adenosine receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Gang Yao, Yoshiko Gogi, Sha Li, G. Kumaravel, Joy Wang, Thomas M. Engber, Eric T. Whalley, Patrick R. Conlon, Hexi Chang, William F. Kiesman, Russell C. Petter	2004	47
5	Studies on adenosine A2a receptor antagonists: comparison of three core heterocycles Bioorganic & Medicinal Chemistry Letters ·Chi B. Vu, P Goulder, Bo Peng, Zahra Valizadehchari, G. Kumaravel, Xiaowei Jin, В. А. Пешехонова, Thomas M. Engber, Paul, R. Y. Pestano, 玉林邓, Russell C. Petter	2004	28
6	Sonic hedgehog delivered by an adeno-associated virus protects dopaminergic neurones against 6-OHDA toxicity in the rat Journal of Neural Transmission ·Brinda Dass, Mahmoud M. Iravani, Chi-Shuan Huang, James Barsoum, Thomas M. Engber, Alphonse Galdes, Peter Jenner	2004	25
7	Long‐acting forms of Sonic hedgehog with improved pharmacokinetic and pharmacodynamic properties are efficacious in a nerve injury model Journal of Pharmaceutical Sciences ·R. Blake Pepinsky, Reneé Shapiro, Shaoshan Wang, Abhijit Chakraborty, Alan Gill, Doreen LePage, Dingyi Wen, Paul Rayhorn, Gerald Horan, Frederick R. Taylor, Ellen A. Garber, Alphonse Galdes, Thomas M. Engber	2002	56
8	Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine Neuroscience ·Thomas M. Engber, Shuyuan Xue, B. E. Jones, Matthew S. Miller, P. Contreras	1998	83
9	Region‐Specific Targets of p42/p44^MAPK Signaling in Rat Brain Journal of Neurochemistry ·Ratan V. Bhat, Thomas M. Engber, James P. Finn, Elizabeth J. Koury, Patricia C. Contreras, Matthew S. Miller, Craig A. Dionne, Kevin M. Walton	1998	48
10	NMDA receptor blockade reverses motor response alterations induced by levodopa Neuroreport ·Thomas M. Engber, Stella M. Papa, Robert C. Boldry, T N Chase	1994	105
11	NBQX inhibits AMPA-induced locomotion after injection into the nucleus accumbens Brain Research ·Robert C. Boldry, Mark D. Kelland, Thomas M. Engber, Thomas N. Chase	1993	17
12	Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists European Journal of Pharmacology ·Stella M. Papa, Thomas M. Engber, Robert C. Boldry, Thomas N. Chase	1993	47
13	Substance P increases release of acetylcholine in the dorsal striatum of freely moving rats Brain Research ·Jeffrey J. Anderson, Thomas N. Chase, Thomas M. Engber	1993	35
14	Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin Brain Research ·Thomas M. Engber, Robert C. Boldry, S. Kuo, Thomas N. Chase	1992	103
15	Effects of chronic Levodopa on D1 and D2 receptor-mediated striatal output Neurochemistry International ·Thomas M. Engber, Zvi Susel, Barton G. Weick, Judith R. Walters, Thomas N. Chase	1992	4
16	Striatal D1 dopamine receptor morphochemistry following continuous or intermittent l-DOPA replacement therapy Experimental Neurology ·Marjorie A. Ariano, Thomas M. Engber, Zvi Susel, Thomas N. Chase	1991	8
17	Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats Brain Research ·Thomas M. Engber, Zvi Susel, S. Kuo, Charles R. Gerfen, Thomas N. Chase	1991	167
18	The K-opioid receptor agonist Spiradoline differentially alters the rotational response to dopamine D1 and D2 agonists European Journal of Pharmacology ·Thomas M. Engber, Robert C. Boldry, Thomas N. Chase	1991	18
19	Prolonged infusion of quinolinic acid into rat striatum as an excitotoxic model of neurodegenerative disease Neuroscience Letters ·Zvi Susel, Thomas M. Engber, S. Kuo, Thomas N. Chase	1991	31
20	Continuous and intermittent levodopa differentially affect basal ganglia function Annals of Neurology ·Jorge L. Juncos, Thomas M. Engber, Rita Raisman, Zvi Susel, Roman Hoang Nguyen, Alain Ploska, Yves Agid, Thomas N. Chase	1989	139

About Thomas M. Engber

Thomas M. Engber is a scholar working on Physiology, Cellular and Molecular Neuroscience, Neurology, Molecular Biology and Organic Chemistry, having authored 61 papers that have together received 5.3k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (20 papers), Neurotransmitter Receptor Influence on Behavior (20 papers), Neurological disorders and treatments (15 papers), Neuroscience and Neuropharmacology Research (14 papers), Receptor Mechanisms and Signaling (11 papers), Neuropeptides and Animal Physiology (9 papers), Adenosine and Purinergic Signaling (8 papers) and Synthesis and Biological Evaluation (7 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (3.8k citations), Neurology (2.2k citations), Physiology (355 citations), Developmental Neuroscience (175 citations) and Cognitive Neuroscience (670 citations). Thomas M. Engber has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Thomas N. Chase, Zvi Susel, Charles R. Gerfen, Lawrence C. Mahan, Frederick J. Monsma, David R. Sibley, Stella M. Papa, Robert C. Boldry, S. Kuo and Thomas N. Chase. Their work appears in journals such as Brain Research, Bioorganic & Medicinal Chemistry Letters, European Journal of Pharmacology, Neuroscience and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact